Navigation Links
PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
Date:6/2/2009

rmation presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) under the DHHS Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, there can be no assurance that the Company will be awarded a contract under the solicitation under BAA-BARDA-09-34. .Further, significant ad
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
2. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
3. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
4. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
5. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
6. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
7. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
8. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
9. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
10. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
11. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  Diplomat, the nation,s ... David Dreyer to the Board of Directors ... director and will also serve as chair of the ... 30 years of accounting, financial, compliance and operating experience ... Dreyer has served as chief financial officer, chief operating ...
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... , September 19, 2014 ... Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), Industry ... (Tray-style, Manifold, & Rotary) & Geography - Global ... defines and segments the lyophilization market on the ... analyses and projections of the market size of ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
... Mindray Medical International Limited (NYSE: MR ... devices worldwide, announced today an agreement to acquire a ... The terms of the agreement were not disclosed as ... Founded in 2003 and based in Suzhou, China, ...
... NEWARK, N.J., July 5, 2011 Regulators are ... punish corporate officers they suspect of wrongdoing—in effect, ... their jobs. It is unclear whether they intend ... dubbed the "death penalty" by some—but at a ...
Cached Medicine Technology:Mindray Medical to Acquire a Controlling Stake in Suzhou Hyssen Electronics 2Mindray Medical to Acquire a Controlling Stake in Suzhou Hyssen Electronics 3Feds Might 'Banish' More Execs for Misconduct, Attorney Says 2Feds Might 'Banish' More Execs for Misconduct, Attorney Says 3
(Date:9/22/2014)... Back pain is a daily reality for ... instant powerful pain relief without taking a dangerous drug may ... have made this very possible. Enter on-line retailer Variety4Kicks, and ... Tens Unit electronic back massager. This premium quality, ... relief each and every day, in a way that's ...
(Date:9/22/2014)... Plugin creators from Pixel Film Studios ... 3D particle emitter made specifically for Final Cut ... plugin to a video adds an element of computer ... Film Studios. “ProSparkle gives users a 3D Sparkle emitter ... ProSparkle users are given total control over creating a ...
(Date:9/22/2014)... The Center for Health Affairs is ... as one of the NorthCoast 99 Award winners. This ... for top talent. This award recognizes these 99 organizations ... that support the attraction, retention and motivation of top ... development and training, compensation and rewards, success and performance, ...
(Date:9/22/2014)... 2014 A Case Management Order (CMO) ... the discovery phase for testosterone lawsuit claims pending in ... of Illinois. Wright & Schulte LLC notes ... submit initial disclosures about potential witnesses and documents in ... continue negotiating the topics in Plaintiff Fact Sheets before ...
(Date:9/22/2014)... Reflecting their position as the leading provider ... Doors and Gates is now offering ornamental iron gates ... offers quality wrought iron ornamental gates that bring elegance ... range of ornamental doors that suit varied purposes and ... ornamental doors wherein their specifications and requirements are meticulously ...
Breaking Medicine News(10 mins):Health News:Online Retailer Variety4Kicks Announces An Over The Counter Tens Unit For Back Pain Relief Is Now Available For Sale 2Health News:Announcing a new ProSparkle Particle Emitter Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 2Health News:The Center for Health Affairs Named to 2014 NorthCoast 99 List 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 2Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 3Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 4Health News:Judge Issues CMO For Testosterone Lawsuits Alleging Heart Attacks and Strokes Caused By "Low T" Drugs Such As Androgel 5Health News:Strictly Doors and Gates Now Adding Ornamental Iron Gates to Their Products Line 2
... and more than 300 people in the UK die from ... permanent disabilities. Now researchers will work on a potential vaccine ... medical charity Meningitis UK. , Although vaccines exist to protect ... to protect against all strains, including the most common in ...
... Immediate Moratorium on Bisphenol,A in Baby Bottles, Food and ... Dozens of state,and national environmental health organizations in the ... the use of bisphenol A (BPA) in baby,bottles and ... of a,new study that demonstrates the toxic chemical BPA ...
... intramuscular injection, study says , , THURSDAY, Feb. 7 ... for delivering DNA vaccines than intramuscular injection, a new ... Genetic Vaccines and Therapy , researchers at the ... protein from the human papillomavirus (HPV), which causes cervical ...
... operating results for the fourth quarter and year ended December 31,2007., Fourth ... $6.883 billion. -- Net income totaled $278 million, ... prior year. -- Adjusted EBITDA totaled $1.153 ... in the prior year. -- Provision for doubtful ...
... DURHAM, NC A novel drug designed to lessen muscle ... at the Duke Clinical Research Institute. Results of the study, ... issue of the journal Circulation, reflect the first time the ... known as KAI-9803, blocks the activity of an enzyme called ...
... 7 Anthera Pharmaceuticals,Inc., a privately held biopharmaceutical ... the Phase II trial,of its novel secretory phospholipaseA2 ... disease will be presented as a late breaker,at ... Scientific Session,on Monday, March 31, 2008 in Chicago, ...
Cached Medicine News:Health News:Meningitis vaccine study gets £200,000 boost 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4Health News:Tattooing Best Way to Deliver DNA Vaccines 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 3Health News:HCA Reports Fourth Quarter - Year End 2007 Results 4Health News:HCA Reports Fourth Quarter - Year End 2007 Results 5Health News:HCA Reports Fourth Quarter - Year End 2007 Results 6Health News:HCA Reports Fourth Quarter - Year End 2007 Results 7Health News:HCA Reports Fourth Quarter - Year End 2007 Results 8Health News:HCA Reports Fourth Quarter - Year End 2007 Results 9Health News:HCA Reports Fourth Quarter - Year End 2007 Results 10Health News:HCA Reports Fourth Quarter - Year End 2007 Results 11Health News:HCA Reports Fourth Quarter - Year End 2007 Results 12Health News:HCA Reports Fourth Quarter - Year End 2007 Results 13Health News:HCA Reports Fourth Quarter - Year End 2007 Results 14Health News:HCA Reports Fourth Quarter - Year End 2007 Results 15Health News:Novel compound may lessen heart attack damage 2Health News:Data From Anthera's Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions 2
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... VIASYS Neurocare - continues the ... diagnosis. Exceptional convenience and speed. Superior ... ,VasoGuard delivers features you won't find ... for cuff attachment and testing. Up ...
... Spine System Evolution offers the latest ... variety of spinal pathologies including degenerative lumbar ... It is also intended for the treaent ... of the L5-S1 vertebra. Levels of pedicle ...
Multiwindow transcranial and peripheral Doppler system....
Medicine Products: